# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-046839
Filing Date
2024-11-19
Accepted
2024-11-19 16:38:04
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1291408
2 |  | ex31-1.htm | EX-31.1 | 14511
3 |  | ex31-2.htm | EX-31.2 | 14446
4 |  | ex32-1.htm | EX-32.1 | 5495
5 |  | ex32-2.htm | EX-32.2 | 5544
6 |  | form10-q_001.jpg | GRAPHIC | 14209
| Complete submission text file | 0001493152-24-046839.txt |  | 5849457

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | tvgn-20240930.xsd | EX-101.SCH | 40640
8 | XBRL CALCULATION FILE | tvgn-20240930_cal.xml | EX-101.CAL | 54067
9 | XBRL DEFINITION FILE | tvgn-20240930_def.xml | EX-101.DEF | 252199
10 | XBRL LABEL FILE | tvgn-20240930_lab.xml | EX-101.LAB | 384966
11 | XBRL PRESENTATION FILE | tvgn-20240930_pre.xml | EX-101.PRE | 332052
69 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 765059

Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41002 | Film No.: 241476785
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)